D. Costello

Effects of Pregnancy and Isoniazid Preventive Therapy on M. tuberculosis Interferon Gamma Response Assays in Women with HIV.

G. Montepiedra, T. Sterling, D. Haas, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effects of Pregnancy and Isoniazid Preventive Therapy on Mycobacterium tuberculosis Interferon Gamma Response Assays in Women With HIV

G. Montepiedra, T. Sterling, D. Haas, 2021 .

Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women.

G. Montepiedra, T. Sterling, G. Theron, 2019, The New England journal of medicine.

Pharmacokinetics and Safety of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in HIV-infected Children With Severe Acute Malnutrition in Sub-Saharan Africa: IMPAACT Protocol P1092

P. Musoke, F. Aweeka, J. Moye, 2021, The Pediatric infectious disease journal.

Pharmacokinetics and Drug‐Drug Interactions of Isoniazid and Efavirenz in Pregnant Women Living With HIV in High TB Incidence Settings: Importance of Genotyping

G. Montepiedra, T. Sterling, D. Haas, 2020, Clinical pharmacology and therapeutics.

Infants Receiving Very Early ART Have High CD4 Counts in the First Year of Life.

S. Spector, M. Cotton, D. Persaud, 2022, Clinical Infectious Diseases.

Etravirine in treatment-experienced HIV-1-infected children 1 year to less than 6 years of age

H. Crauwels, B. Graham, L. Fairlie, 2021, AIDS.

1,3,8-trisubstituted xanthines. Effects of substitution pattern upon adenosine receptor A1/A2 affinity.

P. Blake, R. Hicks, M. Abreu, 1991, Journal of medicinal chemistry.

Effect of pregnancy versus postpartum maternal isoniazid preventive therapy on infant growth in HIV-exposed uninfected infants: a post-hoc analysis of the TB APPRISE trial

G. Montepiedra, T. Sterling, G. Theron, 2023, EClinicalMedicine.

Timing of maternal isoniazid preventive therapy on tuberculosis infection among infants exposed to HIV in low-income and middle-income settings: a secondary analysis of the TB APPRISE trial.

G. Montepiedra, T. Sterling, G. Theron, 2023, The Lancet. Child & adolescent health.

Mouse strain differences in the behavioral effects of Corticotropin-Releasing Factor (CRF) and the CRF antagonist α-helical CRF9–41

M. Abreu, L. Conti, D. Costello, 1994, Pharmacology Biochemistry and Behavior.